• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis" [Biomed. Pharmacother. 107 (2018) 1692-1704].

作者信息

Xu Qiuran, Dou Changwei, Liu Xin, Yang Liu, Ni Chao, Wang Jiahui, Guo Yang, Yang Wei, Tong Xiangmin, Huang Dongsheng

机构信息

Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou, Zhejiang Province 310014, China.

Department of Hepatobiliary Surgery, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou, Zhejiang Province 310014, China; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province 710061, China.

出版信息

Biomed Pharmacother. 2023 Jan;157:113979. doi: 10.1016/j.biopha.2022.113979. Epub 2022 Nov 16.

DOI:10.1016/j.biopha.2022.113979
PMID:36400641
Abstract
摘要

相似文献

1
Corrigendum to "Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis" [Biomed. Pharmacother. 107 (2018) 1692-1704].《林蛙输卵管蛋白水解物（ORPH）通过靶向miR-491-5p/PKM2轴抑制肝癌细胞的生长、转移和糖酵解》的勘误[《生物医学与药物治疗》107（2018）1692-1704]
Biomed Pharmacother. 2023 Jan;157:113979. doi: 10.1016/j.biopha.2022.113979. Epub 2022 Nov 16.
2
Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis.蛙输卵管蛋白水解物（ORPH）通过靶向 miR-491-5p/PKM2 轴抑制 HCC 的生长、转移和糖酵解。
Biomed Pharmacother. 2018 Nov;107:1692-1704. doi: 10.1016/j.biopha.2018.07.071. Epub 2018 Sep 8.
3
Immunostimulatory activity of protein hydrolysate from oviductus ranae on macrophage in vitro.牛蛙输卵管蛋白水解物对体外巨噬细胞的免疫刺激活性。
Evid Based Complement Alternat Med. 2014;2014:180234. doi: 10.1155/2014/180234. Epub 2014 Dec 22.
4
Investigation of the anti-glioma activity of Oviductus ranae protein hydrolysate.研究蛙输卵管蛋白水解物的抗脑胶质瘤活性。
Biomed Pharmacother. 2016 Jul;81:176-181. doi: 10.1016/j.biopha.2016.04.015. Epub 2016 Apr 16.
5
Oviductus Ranae protein hydrolyzate prevents menopausal osteoporosis by regulating TGFβ/BMP2 signaling.蛙输卵管蛋白水解物通过调节 TGFβ/BMP2 信号通路预防绝经后骨质疏松症。
Arch Gynecol Obstet. 2019 Mar;299(3):873-882. doi: 10.1007/s00404-018-5033-9. Epub 2019 Jan 16.
6
Corrigendum to "miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis" [Biomed. Pharmacother. 92 (2017) 1119-1127].《“miR-142-5p通过靶向SDHB并促进有氧糖酵解的产生来促进结直肠癌的发展”的勘误》[《生物医学与药物治疗》92 (2017) 1119 - 1127]
Biomed Pharmacother. 2018 Mar;99:1033-1036. doi: 10.1016/j.biopha.2018.01.031. Epub 2018 Feb 2.
7
Corrigendum to "SNHG11 contributes to NSCLC cell growth and migration by targeting miR-485-5p/BSG axis" [Biomed. Pharmacother. 128 (2020) 110324].《“SNHG11 通过靶向 miR-485-5p/BSG 轴促进 NSCLC 细胞生长和迁移”的勘误》[《生物医学与药物治疗》128 卷（2020 年）110324]
Biomed Pharmacother. 2020 Dec;132:110951. doi: 10.1016/j.biopha.2020.110951. Epub 2020 Nov 2.
8
MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p/HK2/PKM2 axis.MIR210HG 通过 miR-125b-5p/HK2/PKM2 轴调节胰腺癌细胞的糖酵解、增殖和转移。
RNA Biol. 2021 Dec;18(12):2513-2530. doi: 10.1080/15476286.2021.1930755. Epub 2021 Jun 10.
9
Corrigendum to "Kockdown of OIP5-AS1 expression inhibits proliferation, metastasis and EMT progress in hepatoblastoma cells through up-regulating miR-186a-5p and down-regulating ZEB1" [Biomed. Pharmacother. 101 (2018) 14-23].
Biomed Pharmacother. 2020 Sep;129:110598. doi: 10.1016/j.biopha.2020.110598. Epub 2020 Aug 12.
10
Corrigendum to "MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1" [Biomed. Pharmacother. 103 (2018) 645-652].《“MicroRNA-876-5p通过靶向BCL6共抑制因子样1抑制肝细胞癌的上皮-间质转化和转移”的勘误》[《生物医学与药物治疗》103 (2018) 645 - 652]
Biomed Pharmacother. 2023 Jul;163:114804. doi: 10.1016/j.biopha.2023.114804. Epub 2023 Apr 28.